Skip to content

Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin) for intraocular neovascular disease and macular edema

Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin) for intraocular neovascular disease and macular edema - Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014338
Enrollment
3000
Registered
2014-06-25
Start date
2006-06-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ophthalmic neovascular disease Diabetic retinopathy Retinal vein occlusion

Interventions

Sponsors

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Ophthalmic neovasular disease 2) Diabetic retinopathy 3) Retinal vein occlusion 4) Patient 20 years or older at the time of the agreement acquisition 5) The patient that understands this study enough and the agreement in the document by the free will was provided after having received enough explanation

Exclusion criteria

Exclusion criteria: 1) The patient who has difficulty in observation of the fundus for high cataract, corneal clouding 2) Patient younger than 20 years 3) The patient who received other study medication or other clinical experimental medicine within three months before this medication start 4) In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject

Design outcomes

Primary

MeasureTime frame
Ocular fundus

Secondary

MeasureTime frame
Visual acuity Optical coherence tomography Fluorescein angiography Improvement of visual field Improvement of intraocular pressure

Countries

Japan

Contacts

Public ContactTomoaki Tatsumi

Chiba University Graduate School of Medicine Department of Ophthalmology and Visual Science

newyear98mt@yahoo.co.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026